Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes

Abstract

Aims/hypothesis Late-onset type 1 diabetes can be difficult to identify. Measurement of endogenous insulin secretion using C-peptide provides a gold standard classification of diabetes type in longstanding diabetes that closely relates to treatment requirements. We aimed to determine the prevalence and characteristics of type 1 diabetes defined by severe endogenous insulin deficiency after age 30 and assess whether these individuals are identified and managed as having type 1 diabetes in clinical practice. Methods We assessed the characteristics of type 1 diabetes defined by rapid insulin requirement (within 3 years of diagnosis) and severe endogenous insulin deficiency (non-fasting C-peptide <200 pmol/l) in 583 participants with insulin-treated diabetes, diagnosed after age 30, from the Diabetes Alliance for Research in England (DARE) population cohort. We compared characteristics with participants with retained endogenous insulin secretion (>600 pmol/l) and 220 participants with severe insulin deficiency who were diagnosed under age 30. Results Twenty-one per cent of participants with insulin-treated diabetes who were diagnosed after age 30 met the study criteria for type 1 diabetes. Of these participants, 38% did not receive insulin at diagnosis, of whom 47% self-reported type 2 diabetes. Rapid insulin requirement was highly predictive of severe endogenous insulin deficiency: 85% required insulin within 1 year of diagnosis, and 47% of all those initially treated without insulin who progressed to insulin treatment within 3 years of diagnosis had severe endogenous insulin deficiency. Participants with late-onset type 1 diabetes defined by development of severe insulin deficiency had similar clinical characteristics to those with young-onset type 1 diabetes. However, those with later onset type 1 diabetes had a modestly lower type 1 diabetes genetic risk score (0.268 vs 0.279; p < 0.001 [expected type 2 diabetes population median, 0.231]), a higher islet autoantibody prevalence (GAD-, islet antigen 2 [IA2]- or zinc transporter protein 8 [ZnT8]-positive) of 78% at 13 years vs 62% at 26 years of diabetes duration; ( p = 0.02), and were less likely to identify as having type 1 diabetes (79% vs 100%; p < 0.001) vs those with young-onset disease. Conclusions/interpretation Type 1 diabetes diagnosed over 30 years of age, defined by severe insulin deficiency, has similar clinical and biological characteristics to that occurring at younger ages, but is frequently not identified. Clinicians should be aware that patients progressing to insulin within 3 years of diagnosis have a high likelihood of type 1 diabetes, regardless of initial diagnosis. Electronic supplementary material The online version of this article (10.1007/s00125-019-4863-8) contains peer-reviewed but unedited supplementary material, which is avai...

Prevalence and incidence of type 1 diabetes in Ireland: a retrospective cross-sectional study using a national pharmacy claims data from 2016

“…9 Another study from the UK suggests that type 1 diabetes presenting in later life is often unrecognised or misdiagnosed as type 2 diabetes, despite the need to start insulin therapy soon after diagnosis. 45 According to a study from Italy, there are peaks in the incidence of type 1 diabetes in different age groups, with the highest observed in children and adolescents under 15 years, then a significant decrease in age groups 15-29 years, followed by continuously increasing incidence from the age of 29-49 years. 13 In that study, there were no data for older age groups, but our findings demonstrate a similar pattern across all the available comparable age groups.…”

Considering Insulin Secretory Capacity as Measured by a Fasting C-Peptide/Glucose Ratio in Selecting Glucose-Lowering Medications

“…A study using a polygenic risk score based definition of type 1 diabetes revealed that 42 % of all new type 1 manifestations occur after the age of 30 [8]. In contrast, only 38 % of individuals with newly diagnosed type 1 diabetes receive insulin therapy immediately [9]. This underlines that a detection of insulin deficiency present in late onset autoimmune diabetes is particularly important, since the failure of a timely initiation of insulin therapy and/ or an inadequate therapy with ketoacido-Published online: 2020-09-18 sis-promoting agents such as SGLT2 inhibitors could have fatal consequences for type 1 diabetes patients [10].…”

Update on technologies, medicines and treatments

“…Following on from their monogenic diabetes calculator, researchers at Exeter, Oxford and Dundee Universities have developed a new calculator to help clinicians classify whether someone has type 1 diabetes or type 2 diabetes . The need for such a calculator is evident as a study earlier this year from Exeter suggested that nearly 40% of adults who developed type 1 diabetes were initially misdiagnosed and treated for type 2 diabetes .…”